CIZ — Cizzle Biotechnology Holdings Cashflow Statement
0.000.00%
Last trade - 00:00Annual cashflow statement for Cizzle Biotechnology Holdings, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -3.96 | -0.963 | -1.76 | -2.19 | -0.751 |
| Non-Cash Items | 3.15 | 0.148 | 1.09 | 1.55 | 0.042 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.197 | -0.057 | 0.03 | 0.277 | 0.213 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Payable / Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -1.01 | -0.872 | -0.639 | -0.358 | -0.496 |
| Capital Expenditures | — | — | — | — | -0.002 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -0.154 | -0.12 | 0 | — | — |
| Sale of Business | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.154 | -0.12 | 0 | — | -0.002 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 2.03 | 0.595 | 0.305 | 0.579 | 0.249 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.868 | -0.397 | -0.334 | 0.221 | -0.249 |